000			02734cam a2200337 4500
020			_a9241401036
035			_a(Sirsi) 9241401036
060			_aQV 268
242	1	0	_aFiches modèles OMS d' information à l' usage des prescripteurs médicaments utilisés dans les mycobactérioses
242	1	0	_aModelo OMS de información sobre prescripción de medicamentos :medicamentos utilizados en las enfermedades micobacterianas
245	0	0	_aWHO model prescribing information : _bdrugs used in mycobacterial diseases.
246	0		_aDrugs used in mycobacterial diseases
260			_aGeneva : _bWorld Health Organization, _c1991.
300			_a40 p.
500			_achi published by : Beijing : Chinese Anti-Tuberculosis Association.
520	3		_aProvides model prescribing information for some thirteen essential drugs used for the prevention and treatment of tuberculosis, for the treatment of leprosy, and for the treatment of diseases caused by nontuberculous mycobacteria, including localized cutaneous lesions, pulmonary disease, lymphadenitis, and disseminated disease. The first chapter, devoted to tuberculosis, opens with a detailed overview of the disease, its clinical features, and the main principles of prevention, tuberculin testing, and chemotherapy. The special problems of diagnosis and treatment in HIV-infected patients are briefly discussed. Readers are also given detailed information on the properties of antituberculosis drugs, preferred treatment regimens, monitoring of patient compliance and therapeutic response, and the treatment of relapsing and unresponsive disease. Against this background, model prescribing information is presented for ten drugs used in vaccination, chemoprophylaxis, and chemotherapy. Each drug is profiled in terms of its clinical uses, dosage and mode of administration, contraindications and precautions, use in pregnancy, adverse effects, and possible interactions with other drugs. Drugs used in the treatment of leprosy are covered in the second chapter, which also features background information on the disease and the main principles of multi-drug therapy. The final chapter provides prescribing information for drugs used to treat non-specific mycobacterial infections.
546			_achi eng fre spa.
546			_aben.
550			_aWHODOC
561			_aWHO monograph
596			_a4
650	0	2	_aAntitubercular agents.
650	0	2	_aLeprostatic agents.
650	0	2	_aMycobacterium infections _xdrug therapy.
650	0	2	_aPrescriptions, Drug.
690			_aPharmaceuticals and Biologicals.
710	2		_aWorld Health Organization.
856			_uhttps://apps.who.int/iris/
008			910903s1991 1 0 eng
942			_2NLM _cMONOGRAPH
999			_c9794 _d9794